SRP- Ultratrutide™ is an advanced experimental quad-agonist peptide developed for metabolic pathway research, combining GLP-1, GIP, Glucagon, and Ghrelin receptor activity into a single innovative research compound designed to explore body composition, energy utilization, and lean tissue signaling pathways.
- Advanced quad-agonist targeting four metabolic receptor pathways
- Combines GLP-1, GIP, Glucagon, and Ghrelin receptor activity
- Designed for body composition and metabolic pathway research
- Supports investigation of lean tissue signaling mechanisms
- Innovative next-generation research peptide architecture
Vial Size: 3mL
Reviews
There are no reviews yet.